414 related articles for article (PubMed ID: 3131029)
21. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
22. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
24. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
Chu N; Yan B; Zhu L
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
[TBL] [Abstract][Full Text] [Related]
25. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362
[No Abstract] [Full Text] [Related]
26. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
[TBL] [Abstract][Full Text] [Related]
27. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of unfixed continuation phase short-course chemotherapy].
Xiao C; Fu Y; Li Z
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
30. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F
Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969
[No Abstract] [Full Text] [Related]
31. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.
Datta M; Radhamani MP; Selvaraj R; Paramasivan CN; Gopalan BN; Sudeendra CR; Prabhakar R
Tuber Lung Dis; 1993 Jun; 74(3):180-6. PubMed ID: 8369512
[TBL] [Abstract][Full Text] [Related]
32. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
Muratov VV; Pashkov IuN; Pospelov VV
Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
[No Abstract] [Full Text] [Related]
33. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
[TBL] [Abstract][Full Text] [Related]
34. [Controlled clinical study on efficacy of fixed-dose compounds rifater/rifinah in antituberculous chemotherapy].
Zhu L; Yan B; Ma W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):645-7. PubMed ID: 11477887
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of a 4-weekly supplement of rifampicin, pyrazinamide and streptomycin in the continuation phase of a 7-month daily chemotherapy regimen for pulmonary tuberculosis. Tanzania/British Medical Research Council Collaborative Investigation.
S Afr Med J; 1996 Aug; 86(8):960-5. PubMed ID: 8823423
[TBL] [Abstract][Full Text] [Related]
36. Smear-negative pulmonary tuberculosis.
Dutt AK; Stead WW
Semin Respir Infect; 1994 Jun; 9(2):113-9. PubMed ID: 7973170
[TBL] [Abstract][Full Text] [Related]
37. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
[TBL] [Abstract][Full Text] [Related]
38. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
39. Short-course treatment in pulmonary tuberculosis.
East Afr Med J; 1973 Dec; 50(12):672-80. PubMed ID: 4132127
[No Abstract] [Full Text] [Related]
40. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
